These results are consistent with the previously reported data, which suggests that FoxO3a is an important determinant in restraining oncogenic glycolysis in cancers since its knockdown is sufficient to activate cellular glycolysis and increase cell resistance to apoptosis [14]. Here, FOXO3 is linked to cancer.